ELIZABETH KEY: Open Payments
NPI 1619166212 · BEAUFORT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 35 payments from 10 companies in 2025. Trend: 2023 $634 · 2024 $614 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $321 |
| Novo Nordisk Inc | 3 | $90 |
| Merck Sharp & Dohme LLC | 5 | $79 |
| Amgen Inc. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: CAMZYOS, REPATHA, LEQVIO, VERQUVO, JARDIANCE, ELIQUIS, AMVUTTRA, Ozempic.
Industry payments across NC — which companies pay providers there.
